A Link Between Alzheimer's and Type II Diabetes Mellitus? Ca⁺²‐Mediated Signal Control and Protein Localization

Abstract

We propose protein localization dependent signal activation (PLDSA) as a model to describe pre-existing protein partitioning between the cytosol, and membrane surface, as a means to modulate signal activation, specificity, and robustness. We apply PLDSA to explain possible molecular links between type II diabetes mellitus (T2DM) and Alzheimer's disease (AD) by describing Ca -mediated interactions between the Src non-receptor tyrosine kinase and p52Shc adaptor protein. We suggest that these interactions may serve as a contributing factor to disease development and progression. In particular, we propose that signaling response is regulated, in part, by Ca -mediated partitioning of lipid-bound and soluble forms of Src and p52shc. Thus, protein-protein interactions that drive signaling in response to extracellular ligand binding are also mediated by partitioning of signaling proteins between membrane-bound and soluble populations. We propose that PLDSA effects may explain, in part, the evolutionary basis of promiscuous protein interaction domains and their importance in cellular function.

Vitamin D3 Protects Mice from Diquat‐Induced Oxidative Stress through the NF‐κB/Nrf2/HO‐1 Signaling Pathway

“…Nowadays, there are at least 1 billion people that are diagnosed with deficiency of VD around the world in the 21st century, and the trend is increasing by year [20]. More studies support the point that VD not only keeps the health of the skeleton through promoting the absorption of calcium [21] but also has important functions except nutritional effects, including regulating the immune system to exert anti-infective effects and improving the developmental process of noninfectious diseases [22,23]. The antioxidant function of vitamin C has been widely reported; however, the antioxidant effects and possible mechanism of VitD 3 have few studies.…”

Proteasome modulator 9 (PSMD9) gene rs14259 polymorphism in Alzheimer’s disease

“…It was demonstrated that PSMD9 inhibited tumor necrosis factor α (TNF-α)-mediated NF-kB activation via inhibition of nuclear factor kBα (IkBα) proteasome degradation (Hao et al, 2015). TNF-α is one determinant of AD and T2DM onset and progression (Tsutsui and Hays, 2018). In addition, the proteasome-mediated proteolysis plays a recognized role in neuronal development, synaptic plasticity, and protein quality control (Hao et al, 2015).…”

A Potential New Mechanism Linking Type II Diabetes Mellitus and Alzheimer's Disease

“…In this issue of BioEssays, Tsutsui and Hays propose another mechanism that can explain the association between T2DM and AD. The authors propose the hypothesis that increased intracellular Ca 2+ accumulation in diseased cells leads to altered signaling by changing the localization and protein‐protein interactions of key signaling mediators and scaffolding proteins.…”